A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, Scripps Research and IAVI announced Wednesday.
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, Scripps Research and IAVI announced Wednesday.